-
Cost-effectiveness Analysis of Zavegepant in Acute Migraine Treatment
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Adjuvant Pembrolizumab Versus Standard-of-Care (SOC) Immunotherapies (High-Dose interferon Alfa 2-b or Ipilimumab) in High-Risk Resected Melanoma in United States (US)
Mar 10, 2025, 14:00 PM -
Time-Driven Activity-Based Costing in Healthcare: Should We Adjust for Inflation or Reapply the Method?
Mar 10, 2025, 14:00 PM -
Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review on Symptom Burden and Impact of Disease on Quality of Life in Patients With Essential Thrombocythemia
Mar 10, 2025, 14:00 PM -
Ongoing Accelerated Approval Trends and What It Means for Patients
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population
Mar 10, 2025, 14:00 PM -
Changes in Respiratory Medication and Antibiotic Use Among Asthma and COPD Individuals During the Pandemic
Mar 10, 2025, 14:00 PM -
Audience and Publication Profiles in HEOR Research: A Cross-Sectional Analysis of Non-Small-Cell Lung Cancer and Coronary Artery Disease Studies in 2024
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients With C1 Inhibitor Deficiency (Type I/II) and =8 Attacks Per Month
Mar 10, 2025, 14:00 PM -
Gender-Based Gaps In Access to Tricuspid Valve Interventions In England
Mar 10, 2025, 14:00 PM -
Glucocorticoid Exposure and the Risk of Serious Infections in CIDP
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Integrating Artificial Intelligence-Based Retinal Photographic Cardiovascular Disease risk Assessment with Diabetic Retinopathy Screening Programmes: A Multi-Country Analysis
Mar 10, 2025, 14:00 PM -
Prevalence of Diabetes and Its Impact on Hospitalization among Patients with Cancer: A Population-Based Study in the U.S.
Mar 10, 2025, 14:00 PM -
GenAI Goes to ISPOR: Exploratory, Descriptive Analysis of Generative AI Performance for Summarizing and Synthesizing ISPOR Research Abstracts as Sources
Mar 10, 2025, 14:00 PM -
Integration of Survival Analysis Outputs Into Excel-Based Cost-Effectiveness Models Using Generative AI
Mar 10, 2025, 14:00 PM -
Costs And Healthcare Resource Utilization In Patients With Transthyretin Amyloid Cardiomyopathy: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review of the Economic Burden in Patients with Ehlers-Danlos Syndrome in the United States
Mar 10, 2025, 14:00 PM